Spotlight on the human factor: building a foundation for the future of haemophilia A management Report from a symposium on human recombinant FVIII at the World Federation of Hemophilia World Congress, Melbourne, Australia on 12 May 2014

导出原文传递

翻译打印收藏纠错

作者： Kessler, C. ^[1] ; Oldenburg, J. ^[2] ; Ettingshausen, C. Escuriola ^[3] ; Tiede, A. ^[4] ; Khair, K. ^[5] ; Negrier, C. ^[6] ; Klamroth, R. ^[7]

作者单位： Georgetown Univ, Med Ctr, Vincent Lombardi Comprehens Canc Ctr, Div Hematol & Oncol, Washington, DC ^[1] Great Ormond St Hosp Sick Children, London WC1N 3JH, England ^[2] Univ Lyon, Hop Edouard Herriot, Div Hematol, Hemophilia Comprehens Care Ctr, Lyon, France ^[3] Vivantes Klinikum Friedrichshain, Haemophilia Treatment Ctr, Berlin, Germany ^[4] Hannover Med Sch, Hannover, Germany ^[5] Univ Clin, Inst Expt Haematol & Transfus Med, Bonn, Germany ^[6] Haemophilia Ctr Rhein Main HZRM, Morfelden Walldorf, Germany ^[7]

关键词 assays clinical trials haemophilia A Human-cl rhFVIII inhibitors personalized prophylaxis

发布时间 2015-03-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交